Westlake Chemical Partners LP 8-K

What Happened
Westlake Chemical Partners LP filed an 8-K on April 20, 2026, announcing that Jonathan H. Baksht (age 51) was appointed Senior Vice President and Chief Financial Officer and a director of Westlake Chemical Partners GP LLC (the general partner), effective June 15, 2026. Mr. Baksht will also serve as Senior Vice President and Chief Financial Officer of Westlake Corporation, the Partnership’s indirect parent, effective the same date. He succeeds M. Steven Bender, who will retire from the General Partner’s board and transition to Special Advisor to the President of the General Partner on June 15, 2026, and is expected to retire by the end of 2026.

Key Details

• Appointment effective date: June 15, 2026. Form 8-K filed: April 20, 2026. Press release furnished as Exhibit 99.1.
• Incoming CFO background: CFO roles at Fortune Brands Innovations, Inc. (May 2025–Mar 2026), Pactiv Evergreen Inc. (May 2022–May 2025), and Valaris Limited (CFO Nov 2015–Sept 2021); earlier roles in investment banking and consulting.
• Outgoing executive: M. Steven Bender will step down from the board and move from Executive VP & CFO to Special Advisor to the President on June 15, 2026, and will retire by year-end.
• No family relationships, related-party transactions requiring disclosure, or special arrangements reported concerning Mr. Baksht’s appointment.

Why It Matters
A change in the Partnership’s CFO is a material leadership shift that can affect financial strategy, reporting continuity, and investor confidence. The filing confirms a planned, orderly transition with an effective date and a named successor who has recent CFO experience at several public companies. Investors should note the timeline for the transition and that the company publicly disclosed the appointment via a press release.